Sumitomo Pharma (OTCMKTS:DNPUF) Rating Lowered to Hold at Jefferies Financial Group

Jefferies Financial Group cut shares of Sumitomo Pharma (OTCMKTS:DNPUFGet Rating) from a buy rating to a hold rating in a report released on Monday, The Fly reports.

Sumitomo Pharma Stock Performance

Shares of OTCMKTS:DNPUF opened at $5.18 on Monday. Sumitomo Pharma has a 12 month low of $5.15 and a 12 month high of $8.67. The company’s fifty day simple moving average is $6.05 and its 200 day simple moving average is $6.71.

About Sumitomo Pharma

(Get Rating)

Sumitomo Pharma Co, Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia.

Featured Stories

The Fly logo

Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with's FREE daily email newsletter.